Correlation Between Red Light and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Red Light and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Red Light and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Red Light Holland and Mydecine Innovations Group, you can compare the effects of market volatilities on Red Light and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Red Light with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Red Light and Mydecine Innovations.

Diversification Opportunities for Red Light and Mydecine Innovations

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Red and Mydecine is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Red Light Holland and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Red Light is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Red Light Holland are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Red Light i.e., Red Light and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Red Light and Mydecine Innovations

Assuming the 90 days horizon Red Light Holland is expected to under-perform the Mydecine Innovations. But the otc stock apears to be less risky and, when comparing its historical volatility, Red Light Holland is 5.45 times less risky than Mydecine Innovations. The otc stock trades about -0.06 of its potential returns per unit of risk. The Mydecine Innovations Group is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.40  in Mydecine Innovations Group on December 20, 2024 and sell it today you would lose (0.04) from holding Mydecine Innovations Group or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.33%
ValuesDaily Returns

Red Light Holland  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Red Light Holland 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Red Light Holland has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Mydecine Innovations 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Red Light and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Red Light and Mydecine Innovations

The main advantage of trading using opposite Red Light and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Red Light position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Red Light Holland and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance